Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
APA Corp
APA
|
$219M |
| 2 |
SiteOne Landscape Supply
SITE
|
$211M |
| 3 |
Advanced Micro Devices
AMD
|
$185M |
| 4 |
Under Armour
UAA
|
$145M |
| 5 |
WUBA
58.COM INC
WUBA
|
$59.4M |
Top Sells
| 1 |
Amazon
AMZN
|
$364M |
| 2 |
Intuitive Surgical
ISRG
|
$347M |
| 3 |
MON
Monsanto Co
MON
|
$316M |
| 4 |
TripAdvisor
TRIP
|
$226M |
| 5 |
NVIDIA
NVDA
|
$201M |
Sector Composition
| 1 | Consumer Discretionary | 38.28% |
| 2 | Communication Services | 17.18% |
| 3 | Healthcare | 13.62% |
| 4 | Technology | 9.29% |
| 5 | Financials | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
176
Adaptimmune Therapeutics
ADAP
$13.5M
| $5.94M | 0.01% |
1,323,308
+402,324
| +44% | +$1.81M |
|
|
LXFT
177
DELISTED
Luxoft Holding, Inc.
LXFT
| $5.9M | 0.01% |
96,930
| – | – |
|
178
Ambarella
AMBA
$3.44B
| $5.83M | 0.01% |
120,100
+31,000
| +35% | +$1.5M |
|
|
HIMX
179
Himax Technologies
HIMX
$1.45B
| $5.54M | 0.01% |
675,800
-1,928,717
| -74% | -$15.8M |
|
|
BGB
180
Blackstone Strategic Credit 2027 Term Fund
BGB
$561M
| $5.22M | 0.01% |
327,750
+199,060
| +155% | +$3.17M |
|
181
Nuveen Credit Strategies Income Fund
JQC
$750M
| $5.03M | 0.01% |
583,518
+352,618
| +153% | +$3.04M |
|
|
KDNY
182
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.82M | 0.01% |
84,540
+26,540
| +46% | +$1.51M |
|
183
HUTCHMED
HCM
$2.55B
| $3.91M | 0.01% |
167,547
+9,655
| +6% | +$225K |
|
|
ONC
184
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
| $3.35M | ﹤0.01% |
74,424
+3,559
| +5% | +$160K |
|
185
Wipro
WIT
$28.6B
| $3.07M | ﹤0.01% |
1,572,709
-289,504
| -16% | -$565K |
|
186
Rio Tinto
RIO
$101B
| $2.99M | ﹤0.01% |
70,626
| – | – |
|
187
Regeneron Pharmaceuticals
REGN
$60.1B
| $2.7M | ﹤0.01% |
5,500
| – | – |
|
|
FCT
188
First Trust Senior Floating Rate Income Fund II
FCT
$263M
| $2.45M | ﹤0.01% |
183,676
| – | – |
|
|
SOS
189
SOS Ltd
SOS
$11.3M
| $1.72M | ﹤0.01% |
+40
| New | +$1.72M |
|
190
SK Telecom
SKM
$8.32B
| $1.56M | ﹤0.01% |
36,883
+1,523
| +4% | +$64.4K |
|
191
Acacia Research
ACTG
$322M
| $1.5M | ﹤0.01% |
365,820
| – | – |
|
|
BIOA
192
DELISTED
BioAmber Inc.
BIOA
| $1.49M | ﹤0.01% |
579,540
| – | – |
|
|
FOMX
193
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.02M | ﹤0.01% |
219,400
| – | – |
|
194
NetEase
NTES
$84.3B
| $994K | ﹤0.01% |
16,535
+7,255
| +78% | +$436K |
|
195
Korea Electric Power
KEP
$17.4B
| $816K | ﹤0.01% |
45,400
+32,400
| +249% | +$582K |
|
196
Xylem
XYL
$34.5B
| $302K | ﹤0.01% |
5,457
| – | – |
|
197
Ecolab
ECL
$78B
| $269K | ﹤0.01% |
2,027
| – | – |
|
|
KITE
198
DELISTED
Kite Pharma, Inc.
KITE
| $266K | ﹤0.01% |
2,564
| – | – |
|
199
Donaldson
DCI
$9.39B
| – | – |
-253,959
| Closed | -$11.6M |
|
200
PACCAR
PCAR
$51.6B
| – | – |
-305,903
| Closed | -$13.7M |
|